GE Healthcare jumped ahead of competitors in the race to cut patient dose with the commercial release in 2008 of its Adaptive Statistical Iterative Reconstruction (ASIR), the first software to clean up CT images and, in the process, allow dramatic reductions -- up to 50% -- in patient radiation dose. In the first day of this year’s ISCT symposium, iterative reconstruction was hailed repeatedly as the leading solution to the hottest issue in CT patient safety.
GE Healthcare jumped ahead of competitors in the race to cut patient dose with the commercial release in 2008 of its Adaptive Statistical Iterative Reconstruction (ASIR), the first software to clean up CT images and, in the process, allow dramatic reductions-up to 50%-in patient radiation dose. In the first day of this year’s ISCT symposium, iterative reconstruction was hailed repeatedly as the leading solution to the hottest issue in CT patient safety.
Yet providers have been slow to adopt this technology. Only about 330 CTs are currently running ASIR, despite being standard on GE’s flagship, the Discovery CT750 HD, since the end of 2008, commercially available on the VCT since mid-2009, and available outside the U.S on the BrightSpeed 16 for a year. ASIR is also available as a field upgrade for certain high-performance systems.
But J. Eric Stahre, GE’s general manager of global premium CT, says he is pleased with the market reception, explaining that ASIR represents a new kind of technology and the CT community is following a longstanding pattern of cautious adoption. Momentum is building and will continue to do so, Stahre said, as scientific presentations on the clinical value of ASIR mount.
More than 20 speakers at RSNA 2009 documented the ability of the technology to cut patient dose substantially, he said. Others have addressed this ability at the ISCT symposium. One said ASIR is to the current standard, filtered back projection, as color television was to black and white. Incorporating model-based (MBIR) algorithms, the next generation of IR, the speaker said, will take IR to the CT equivalent of LED-based TVs.
MBIR is currently in testing at GE luminary sites and will be commercialized later this year outside the U.S. It will not, however, take the place of ASIR, according to Stahre. It will be used on special cases, complementing, rather than replacing, ASIR.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.